FDA scientific advice meeting provides guidance on planned Phase 3 study of radiodiagnostic lead candidate in treatment-resistant hypertension / primary…
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"),…
ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on…
SAN FRANCISCO, Dec. 2, 2025 /PRNewswire/ -- Over the past few months, there has been some curiosity about CoVet's long-term direction.…
WOKING, United Kingdom, Dec. 2, 2025 /PRNewswire/ -- IDBS, a Danaher company and leading provider of cloud-based data management software…
*Only Dog Genetics Company Uniting Science, Personalization and Lifelong Guidance Striving to Help Pets Live Longer, Happier, Healthier Lives*LOS ANGELES,…
Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modelingSEOUL, South Korea, Dec. 2,…
BOSTON, Dec. 2, 2025 /PRNewswire/ -- Clairity, developer of the first image-only AI model authorized by the U.S. Food and…
Taipei, Taiwan, Dec. 02, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology…
MENLO PARK, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a molecular diagnostics company with a mission…